Tang Kevin sold 18,300 shares of Boundless Bio, Inc. at $2.97 for −$54.4k on Aug 26, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
10% owner
10%
Filed Aug 28, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$54,351Shares × reported price
Shares traded
18,300Common Stock
Price per share
$2.97Reported price. Read footnotes for ranges.
% of reported position traded
0.64%This security and ownership context
Holdings after
2,840,635Indirect · See Footnote
Trade date
Aug 26, 2026Sell
Filed
Aug 28, 2026, 4:16 PM ET2-day reporting delay
Accession
0001178579-26-000018Code S · Transaction 117407
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 2,858,935 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

BOLD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BOLD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d +1.4%30d −6%90d180d1y

Footnotes in full

F1: The Reporting Persons have delivered to the Issuer the full amount of the disgorgeable profit arising the sale reported herein, in the amount of $10,046.70. F2: The price reported herein is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $3.03. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares sold at each price within the range set forth in Footnote 2. F3: Tang Capital Partners, LP ("TCP") beneficially owns 655,170 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 887,715 shares, Tang Capital Partners III, Inc. ("TCP III") beneficially owns 655,161 shares, and Tang Capital Partners IV, Inc. ("TCP IV") beneficially owns 642,589 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV.